Scholarlink

Regulatory exclusivities are applicable to medicinal products, without distinguishing between different classes of drugs, with the exception of orphan drugs, which are intended for the treatment of rare diseases, and paediatric drugs, which are medicines for the paediatric population. Regulatory exclusivities, both classic and those pertaining to orphan and paediatric drugs, do not specifically address PM drugs. However, PM may benefit from some of these exclusivities.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Regulatory Exclusivities

  • 章节

  • 发表日期：

    2026年

查看全文
  • Laura Valtere

摘要

Regulatory exclusivities are applicable to medicinal products, without distinguishing between different classes of drugs, with the exception of orphan drugs, which are intended for the treatment of rare diseases, and paediatric drugs, which are medicines for the paediatric population. Regulatory exclusivities, both classic and those pertaining to orphan and paediatric drugs, do not specifically address PM drugs. However, PM may benefit from some of these exclusivities.